Results 191 to 200 of about 1,130,525 (354)

The Director of Nursing Service

open access: bronze, 1949
Constance Long
openalex   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt   +7 more
wiley   +1 more source

Validity of the Medication Safety Self‐Assessment for Long‐Term Care tool in Australian long‐term care: a RAND appropriateness method study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims The validity of using the Canadian Medication Safety Self‐Assessment for Long‐Term Care (MSSA‐LTC) tool in the international context is unknown. This study aims to determine the face and content validity of the Canadian MSSA‐LTC tool for assessing medication safety‐related processes in the Australian long‐term care (LTC) setting.
Ramesh Sharma Poudel   +3 more
wiley   +1 more source

Nursing Service in a Tuberculosis Sanatorium

open access: bronze, 1954
Helen Blackman, M Kathleen
openalex   +1 more source

Home - About - Disclaimer - Privacy